SG158841A1 - Genes - Google Patents
GenesInfo
- Publication number
- SG158841A1 SG158841A1 SG200908691-9A SG2009086919A SG158841A1 SG 158841 A1 SG158841 A1 SG 158841A1 SG 2009086919 A SG2009086919 A SG 2009086919A SG 158841 A1 SG158841 A1 SG 158841A1
- Authority
- SG
- Singapore
- Prior art keywords
- seq
- sequence shown
- sequence
- genes
- pdcd6
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
- 241000699802 Cricetulus griseus Species 0.000 abstract 1
- 102100026693 FAS-associated death domain protein Human genes 0.000 abstract 1
- 102100037819 Fas apoptotic inhibitory molecule 1 Human genes 0.000 abstract 1
- 101000911074 Homo sapiens FAS-associated death domain protein Proteins 0.000 abstract 1
- 101000878509 Homo sapiens Fas apoptotic inhibitory molecule 1 Proteins 0.000 abstract 1
- 101000734646 Homo sapiens Programmed cell death protein 6 Proteins 0.000 abstract 1
- 102100034785 Programmed cell death protein 6 Human genes 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64033304P | 2004-12-30 | 2004-12-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG158841A1 true SG158841A1 (en) | 2010-02-26 |
Family
ID=36615341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200908691-9A SG158841A1 (en) | 2004-12-30 | 2005-12-28 | Genes |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US7846894B2 (enExample) |
| EP (6) | EP1997890A1 (enExample) |
| JP (1) | JP5089400B2 (enExample) |
| KR (1) | KR20070082597A (enExample) |
| CN (3) | CN101875692A (enExample) |
| AU (1) | AU2005322686B2 (enExample) |
| IL (1) | IL183361A0 (enExample) |
| SG (1) | SG158841A1 (enExample) |
| WO (1) | WO2006071200A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013234046B2 (en) | 2012-03-16 | 2017-09-07 | University Health Network | Methods and compositions for modulating Toso activity |
| EP2674495A1 (en) * | 2012-06-14 | 2013-12-18 | Sanofi | CHO expression system |
| WO2014068048A1 (en) * | 2012-11-05 | 2014-05-08 | Celonic Ag | Expression system |
| CA2917077A1 (en) | 2013-07-03 | 2015-01-08 | University Health Network | Antibodies to toso |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| CN107630038A (zh) * | 2017-09-15 | 2018-01-26 | 浙江大学 | 提高老年大鼠骨髓间充质干细胞移植后生存能力的方法 |
| WO2019180607A1 (en) * | 2018-03-19 | 2019-09-26 | Centre For Cellular And Molecular Platforms | A vector, a host cell and a method thereof |
| CN108359632A (zh) * | 2018-03-30 | 2018-08-03 | 吉林冠界生物技术有限公司 | Mdck细胞系、复制病毒的方法及其应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| JPH02500329A (ja) | 1987-05-21 | 1990-02-08 | クリエイテイブ・バイオマリキユールズ・インコーポレーテツド | ターゲット化多機能蛋白質 |
| DE68927933T2 (de) | 1988-09-02 | 1997-08-14 | Dyax Corp | Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen |
| FI903489A7 (fi) | 1988-11-11 | 1990-07-10 | Medical Res Council | Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö |
| US5641670A (en) | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| US6747138B1 (en) | 1995-04-03 | 2004-06-08 | Regents Of The University Of Michigan | Methods and compositions for regulating Fas-associated apoptosis |
| EP0816497A3 (en) * | 1996-06-26 | 1999-12-22 | Smithkline Beecham Corporation | Human requiem polypeptide for apoptosis |
| US6544523B1 (en) | 1996-11-13 | 2003-04-08 | Chiron Corporation | Mutant forms of Fas ligand and uses thereof |
| GB9625283D0 (en) * | 1996-12-04 | 1997-01-22 | Janssen Pharmaceutica Nv | Vertebrate homologues of unc-53 protein of c.elegans or functional eqivalents thereof and cdna sequences coding for said homologue |
| US20040143111A1 (en) * | 1997-04-17 | 2004-07-22 | Incyte Corporation | Novel apoptosis-associated protein |
| US6451759B1 (en) | 1998-01-14 | 2002-09-17 | The Regents Of The University Of California | Noncleavable Fas ligand |
| AU3753099A (en) * | 1998-04-21 | 1999-11-08 | Trustees Of Boston University | Novel genes and methods that modulate apoptosis |
| US6683168B1 (en) | 1998-04-21 | 2004-01-27 | Boston Medical Center Corporation | Genes and methods that modulate apoptosis |
| US6015712A (en) * | 1999-07-19 | 2000-01-18 | Isis Pharmaceuticals Inc. | Antisense modulation of FADD expression |
| US6586206B1 (en) * | 1999-09-27 | 2003-07-01 | Genentech, Inc. | Methods for making recombinant proteins using apoptosis inhibitors |
| US7575860B2 (en) * | 2000-03-07 | 2009-08-18 | Evans David H | DNA joining method |
| US20040023385A1 (en) * | 2002-08-05 | 2004-02-05 | Isis Pharmaceuticals Inc. | Antisense modulation of requiem expression |
| WO2004070025A2 (en) * | 2003-02-05 | 2004-08-19 | Juan Saus | Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders |
| CN1548054A (zh) * | 2003-05-08 | 2004-11-24 | 陆爱丽 | 预防或治疗sars冠状病毒的药物 |
-
2005
- 2005-12-28 KR KR1020077013799A patent/KR20070082597A/ko not_active Ceased
- 2005-12-28 EP EP08014674A patent/EP1997890A1/en not_active Withdrawn
- 2005-12-28 CN CN2010102090432A patent/CN101875692A/zh active Pending
- 2005-12-28 EP EP05817618A patent/EP1831366A2/en not_active Withdrawn
- 2005-12-28 EP EP10012420A patent/EP2298888A1/en not_active Withdrawn
- 2005-12-28 CN CN2010102090324A patent/CN101875957A/zh active Pending
- 2005-12-28 JP JP2007549327A patent/JP5089400B2/ja not_active Expired - Fee Related
- 2005-12-28 EP EP10012419A patent/EP2298887A1/en not_active Withdrawn
- 2005-12-28 CN CNA2005800488118A patent/CN101133156A/zh active Pending
- 2005-12-28 EP EP10012421A patent/EP2298889A1/en not_active Withdrawn
- 2005-12-28 EP EP10012422A patent/EP2298890A1/en not_active Withdrawn
- 2005-12-28 SG SG200908691-9A patent/SG158841A1/en unknown
- 2005-12-28 AU AU2005322686A patent/AU2005322686B2/en not_active Ceased
- 2005-12-28 WO PCT/SG2005/000433 patent/WO2006071200A2/en not_active Ceased
-
2007
- 2007-05-21 IL IL183361A patent/IL183361A0/en unknown
- 2007-07-02 US US11/824,740 patent/US7846894B2/en not_active Expired - Fee Related
-
2010
- 2010-11-15 US US12/946,690 patent/US20110129927A1/en not_active Abandoned
-
2011
- 2011-04-13 US US13/086,028 patent/US20110318831A1/en not_active Abandoned
- 2011-04-13 US US13/086,075 patent/US20110318316A1/en not_active Abandoned
- 2011-04-13 US US13/086,263 patent/US20110318317A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN101133156A (zh) | 2008-02-27 |
| EP2298888A1 (en) | 2011-03-23 |
| CN101875957A (zh) | 2010-11-03 |
| CN101875692A (zh) | 2010-11-03 |
| AU2005322686B2 (en) | 2012-01-19 |
| US20110318316A1 (en) | 2011-12-29 |
| EP1997890A1 (en) | 2008-12-03 |
| EP2298887A1 (en) | 2011-03-23 |
| US20110129927A1 (en) | 2011-06-02 |
| JP5089400B2 (ja) | 2012-12-05 |
| US20110318831A1 (en) | 2011-12-29 |
| IL183361A0 (en) | 2007-09-20 |
| US20110318317A1 (en) | 2011-12-29 |
| WO2006071200A2 (en) | 2006-07-06 |
| JP2008526200A (ja) | 2008-07-24 |
| US20080295190A1 (en) | 2008-11-27 |
| WO2006071200A3 (en) | 2007-01-25 |
| EP2298889A1 (en) | 2011-03-23 |
| KR20070082597A (ko) | 2007-08-21 |
| AU2005322686A1 (en) | 2006-07-06 |
| EP1831366A2 (en) | 2007-09-12 |
| EP2298890A1 (en) | 2011-03-23 |
| US7846894B2 (en) | 2010-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI320645B (en) | Switching schemes for multiple antennas | |
| WO2007035600A3 (en) | Natriuretic activities | |
| YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
| PT2332968T (pt) | Péptidos alfa-helicoidais adequados para a activação ou inibição da morte celular | |
| WO2005007818A3 (en) | Exo-specific amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof | |
| DK0698105T3 (da) | Nukleotidsekvenser til styring af ekspressionen af DNAsekvenser i en værtscelle | |
| SG158141A1 (en) | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | |
| AU2003261437A8 (en) | Fuel cell voltage feedback control system | |
| WO2003074546A8 (de) | Streptavidin-bindungspeptid | |
| WO2004087874A3 (en) | Novel nucleic acids and polypeptides | |
| IL158159A0 (en) | NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha-21 GENE | |
| SG10201803541TA (en) | Biologically active c-terminal arginine-containing peptides | |
| WO2001049721A3 (en) | Bacterial genes and proteins that are essential for cell viability and their uses | |
| WO2005049806A3 (en) | Novel nucleic acids and polypeptides | |
| AU6724794A (en) | GRB3-3 gene, its variants and their uses | |
| TW200722436A (en) | A peptide-immunoglobulin-conjugate | |
| WO2006071200A3 (en) | Chinese hamster apoptosis-related genes | |
| MX2009009370A (es) | Conjugados del complemento de peptido. | |
| WO2003093305A3 (en) | Teneurin c-terminal associated peptides (tcap) and uses thereof | |
| WO2006127822A3 (en) | Scytovirin domain 1 related polypeptides | |
| AU2003238955A1 (en) | Aquariums switching current water director (scwd) | |
| AU2003282465A8 (en) | Isolated mammalian membrane protein genes | |
| WO2007144492A3 (fr) | Peptides a activite anti-proliferative | |
| GB0125773D0 (en) | Constructs | |
| EP1183266A4 (en) | INVERTED RETRO PEPTIDES DERIVED FROM LEUKEMIA INHBITION FACTOR |